Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Shrinking team NBB
FTE fell two years in a row, from 2.5 to 1.
-
Figures corrected NBB
Corrected annual account filed for 2023, 2024.
-
Busy address KBO
23 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
LUCIMED from Wavre, company number BE0873183112, closed financial year 2025 with a result of € 932,856 after tax. For that financial year LUCIMED recorded a gross margin of € 1.5 million and equity of € 2.6 million. Compared with financial year 2024, the result moved from € 193,255 to € 932,856. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 5, 2026.
€ 2.6 million
▲ 55% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 932,856
▲ € 739,602 vs 2024
Profit after tax over the fiscal year.
€ 531,201
▼ 44% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 2.4 million.
People and assets in 2025
1
▼ 0.9 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 76,538
▼ 29% vs 2024
€ 76,500 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 3,313
▼ 64% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1.6 million
▲ 50% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 377,719
▲ 276% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | - | € 2,509,194 | € 3,776,925 | - | |
| Gross margin | € 501,046 | € 557,009 | € 456,622 | € 1,495,723 | ▲ 228% |
| Profit after taxes | € 200,260 | € 265,001 | € 193,255 | € 932,856 | ▲ € 739,602 |
| Equity | € 1,240,010 | € 1,505,046 | € 1,698,301 | € 2,631,157 | ▲ 55% |
| Total debts | € 785,675 | € 1,163,873 | € 1,385,904 | € 2,177,721 | ▲ 57% |
| Cash | € 366,813 | € 259,732 | € 947,824 | € 531,201 | ▼ 44% |
| Retained profit | € 1,050,010 | € 1,315,046 | € 1,508,301 | € 2,441,157 | ▲ 62% |
| Bank debt | € 347 | € 16,757 | € 0 | € 0 | |
| Balance sheet total | € 2,025,685 | € 2,668,919 | € 3,084,205 | € 4,808,878 | ▲ 56% |
| Employees (FTE) | 2.6 | 2.5 | 1.9 | 1 | ▼ 0.9 |
Key figures of LUCIMED, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 March 2027.
What happened to LUCIMED?
What happened at LUCIMED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Eric DELLOYE stepped down as director. NBB
- Corrected annual accounts filed for financial year 2024. filed late Source: NBB ↗
- Eric DELLOYE became a director. NBB
- New establishment in Wavre. KBO
- Start of the company according to the CBE. KBO
In short
From € 200,260 profit in 2022 to € 932,856 profit in 2025.
Paid € 624,542 in corporate taxes since 2022.
Best year ever: 2025, with € 932,856 profit.
On average € 1.5 million of value added per employee in 2025.
Management
Behind LUCIMED are Monique TILMAN, Emmanuel DELLOYE and Jacques TILMAN. The shares are held by Emmanuel Delloye (38.5%), Eric Delloye (20%), Monique Tilman (6.5%), Jacques Tilman (6.5%), Charlotte Tilman (6.4%) and Marguerite Tilman (6.4%).
Directors
According to the 2025 annual accounts
Monique TILMAN
Director
Emmanuel DELLOYE
Managing director
Owns 38.5% directly
Also active at: Tennis et Hockey Club Hutois, FONDERIE ET MECANIQUE DE LA SAMBRE, Emmanuel Delloye Management, BULON METAL SERVICES
Jacques TILMAN
Director
Eric DELLOYE
Chairman of the board
since 2023 · until 2029
Shareholders
Emmanuel Delloye · director
38.5%
Eric Delloye
20%
Monique Tilman
6.5%
Jacques Tilman
6.5%
Charlotte Tilman
6.4%
Marguerite Tilman
6.4%
Caroline Tilman
6.4%
François Tilman
6.4%
Philippe Miller
2.9%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Rue de Genval 20
1301 Wavre
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 23 companies are registered at this address.
All companies at this address →SHOPPINFO
PETROGESTION
€ -550 gross margin · 2025
SECO - INVEST
€ 39,946 gross margin · 2025
INTERNATIONAL SERVICES & ADVICES
€ 59,926 gross margin · 2025
ERPICUM
€ 334,624 gross margin · 2025
+18 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0873.183.112
- VAT number
- BE 0873.183.112
- Registered office
- Rue de Genval 20, 1301 Wavre
- Names & denominations
- LUCIMED
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 14 April 2005
- Peppol
- Active · Active since 12 Dec 2025
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Activiteiten van kuuroorden, sauna’s en stoombaden
Overige lichaamsverzorging
Sauna's, solaria, baden enz.
Groothandel in farmaceutische producten